ArticleClinical and translational radiation oncology2021

Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma.

Rutvij A Khanolkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.